Neil Lerner's most recent trade in Compass Therapeutics Inc was a trade of 20,000 Common Stock done at an average price of $1.4 . Disclosure was reported to the exchange on April 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Compass Therapeutics Inc | Neil Lerner | CHIEF ACCOUNTING OFFICER | Purchase of securities on an exchange or from another person at price $ 1.42 per share. | 07 Apr 2025 | 20,000 | 320,000 | - | 1.4 | 28,400 | Common Stock |
| Compass Therapeutics Inc | Neil Lerner | SVP, CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Psychemedics Corp. | Neil Lerner | VP - Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 10,000 | 25,866 (0%) | 0% | 0 | Common Stock, $.005 Par Value | |
| Psychemedics Corp. | Neil Lerner | VP - Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 3,000 | 3,000 | - | - | Stock Option (Right to Buy) |